{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:16:00Z","timestamp":1793272560470,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CSL Behring GmbH"},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hereditary angioedema (HAE) with normal C1 inhibitor (C1-INH) (HAEnCI) is associated with skin swellings, abdominal attacks, and the risk of asphyxia due to upper airway obstruction. Several different gene mutations linked to the HAE phenotype have been identified. Our aim was to qualitatively assess and describe the clinical differentiators of these genetically identified HAEnCI types. To achieve this, we performed a systematic literature review of patients with angioedema symptoms and a genetically confirmed diagnosis of an HAEnCI type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A systematic literature search, conducted in March 2020, returned 132 records, 43 of which describe patients with symptoms of angioedema and a genetically confirmed diagnosis of an HAEnCI type. Overall, this included 602 patient cases from 220 families. HAEnCI with a mutation in the coagulation factor XII gene (\n                      <jats:italic>F12<\/jats:italic>\n                      ) (HAE-FXII) was diagnosed in 446 patients from 185 families (male:female ratio\u2009=\u20091:10). Estrogens (oral contraceptives, hormonal replacement therapy, and pregnancy) negatively impacted the course of disease in most female patients (252 of 277). Asphyxia occurred in 2 of 446 patients. On-demand and\/or long-term prophylaxis treatment included C1-INH concentrates, icatibant, progestins, and tranexamic acid. HAEnCI with a specific mutation in the plasminogen gene (HAE-PLG) was diagnosed in 146 patients from 33 families (male:female ratio\u2009=\u20091:3). Estrogens had a negative influence on the course of disease in the minority of female patients (14 of 62). Tongue swelling was an important clinical feature. Asphyxia occurred in 3 of 146 patients. On-demand treatment with icatibant and C1-INH concentrate and long-term prophylaxis with progestins and tranexamic acid were effective. HAEnCI with a specific mutation in the angiopoietin-1 gene (HAE-ANGPT1) was diagnosed in 4 patients from 1 family and HAEnCI with a specific mutation in the kininogen-1 gene (HAE-KNG1) in 6 patients from 1 family.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A number of clinical differentiators for the different types of HAEnCI have been identified which may support clinicians to narrow down the correct diagnosis of HAEnCI prior to genetic testing and thereby guide appropriate treatment and management decisions. However, confirmation of the causative gene mutation by genetic testing will always be required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01570-x","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T05:02:47Z","timestamp":1602738167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-4577","authenticated-orcid":false,"given":"Konrad","family":"Bork","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Machnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhransu","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"issue":"1","key":"1570_CR1","first-page":"23","volume":"34","author":"BK Angioedema","year":"2013","unstructured":"Angioedema BK. Immunol Allergy Clin North Am. 2013;34(1):23\u201331.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"1570_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/all.12380","volume":"69","author":"M Cicardi","year":"2014","unstructured":"Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602\u201316.","journal-title":"Allergy"},{"key":"1570_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0002-9343(63)90162-1","volume":"35","author":"VH Donaldson","year":"1963","unstructured":"Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am J Med. 1963;35:37\u201344.","journal-title":"Am J Med"},{"issue":"1","key":"1570_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198707023170101","volume":"317","author":"D Stoppa-Lyonnet","year":"1987","unstructured":"Stoppa-Lyonnet D, Tosi M, Laurent J, Sobel A, Lagrue G, Meo T. Altered C1 inhibitor genes in type I hereditary angioedema. N Engl J Med. 1987;317(1):1\u20136.","journal-title":"N Engl J Med"},{"issue":"3","key":"1570_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1067\/mai.2000.108106","volume":"106","author":"KE Binkley","year":"2000","unstructured":"Binkley KE, Davis A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106(3):546\u201350.","journal-title":"J Allergy Clin Immunol"},{"issue":"9225","key":"1570_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"K Bork","year":"2000","unstructured":"Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225):213\u20137.","journal-title":"Lancet"},{"issue":"4","key":"1570_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1570_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","volume":"124","author":"K Bork","year":"2009","unstructured":"Bork K, Wulff K, Hardt J, Witzke G, Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol. 2009;124(1):129\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1570_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","volume":"141","author":"V Bafunno","year":"2018","unstructured":"Bafunno V, Firinu D, D\u2019Apolito M, Cordisco G, Loffredo S, Leccese A, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141(3):1009\u201317.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1570_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/all.13270","volume":"73","author":"K Bork","year":"2018","unstructured":"Bork K, Wulff K, Steinmuller-Magin L, Braenne I, Staubach-Renz P, Witzke G, et al. Hereditary angioedema with a mutation in the plasminogen gene. Allergy. 2018;73(2):442\u201350.","journal-title":"Allergy"},{"issue":"12","key":"1570_CR11","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/all.13869","volume":"74","author":"K Bork","year":"2019","unstructured":"Bork K, Wulff K, Rossmann H, Steinmuller-Magin L, Braenne I, Witzke G, et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin. Allergy. 2019;74(12):2479\u201381.","journal-title":"Allergy"},{"key":"1570_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/all.14454","author":"A Ariano","year":"2020","unstructured":"Ariano A, D\u2019Apolito M, Bova M, Bellanti F, Loffredo S, D\u2019Andrea G, et al. A myoferlin gain-of-function variant associates with a new type of hereditary angioedema. Allergy. 2020. https:\/\/doi.org\/10.1111\/all.14454.","journal-title":"Allergy"},{"issue":"8","key":"1570_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/all.12648","volume":"70","author":"K Bork","year":"2015","unstructured":"Bork K, Wulff K, Witzke G, Hardt J. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Allergy. 2015;70(8):1004\u201312.","journal-title":"Allergy"},{"issue":"1","key":"1570_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","volume":"141","author":"K Bork","year":"2011","unstructured":"Bork K, Wulff K, Meinke P, Wagner N, Hardt J, Witzke G. A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol. 2011;141(1):31\u20135.","journal-title":"Clin Immunol"},{"issue":"1","key":"1570_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","volume":"149","author":"N Kiss","year":"2013","unstructured":"Kiss N, Barabas E, Varnai K, Halasz A, Varga LA, Prohaszka Z, et al. Novel duplication in the F12 gene in a patient with recurrent angioedema. Clin Immunol. 2013;149(1):142\u20135.","journal-title":"Clin Immunol"},{"issue":"6","key":"1570_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/509899","volume":"79","author":"S Cichon","year":"2006","unstructured":"Cichon S, Martin L, Hennies HC, Muller F, Van Driessche K, Karpushova A, et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet. 2006;79(6):1098\u2013104.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1570_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jaci.2007.07.002","volume":"120","author":"L Martin","year":"2007","unstructured":"Martin L, Raison-Peyron N, Nothen MM, Cichon S, Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol. 2007;120(4):975\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1570_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","volume":"156","author":"L Bouillet","year":"2007","unstructured":"Bouillet L, Ponard D, Rousset H, Cichon S, Drouet C. A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. Br J Dermatol. 2007;156(5):1063\u20135.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1570_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/00313020701716433","volume":"40","author":"CG Bell","year":"2008","unstructured":"Bell CG, Kwan E, Nolan RC, Baumgart KW. First molecular confirmation of an Australian case of type III hereditary angioedema. Pathology. 2008;40(1):82\u20133.","journal-title":"Pathology"},{"issue":"4","key":"1570_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jaci.2008.12.010","volume":"123","author":"QL Duan","year":"2009","unstructured":"Duan QL, Binkley K, Rouleau GA. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. J Allergy Clin Immunol. 2009;123(4):906\u201310.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1570_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1398-9995.2008.01764.x","volume":"64","author":"A Prieto","year":"2009","unstructured":"Prieto A, Tornero P, Rubio M, Fernandez-Cruz E, Rodriguez-Sainz C. Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III. Allergy. 2009;64(2):284\u20136.","journal-title":"Allergy"},{"issue":"1","key":"1570_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaci.2008.10.056","volume":"123","author":"F Hentges","year":"2009","unstructured":"Hentges F, Hilger C, Kohnen M, Gilson G. Angioedema and estrogen-dependent angioedema with activation of the contact system. J Allergy Clin Immunol. 2009;123(1):262\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1570_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.06.013","volume":"56","author":"N Nagy","year":"2009","unstructured":"Nagy N, Greaves MW, Tanaka A, McGrath JA, Grattan CE. Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema. J Dermatol Sci. 2009;56(1):62\u20134.","journal-title":"J Dermatol Sci"},{"key":"1570_CR24","doi-asserted-by":"publisher","first-page":"957507","DOI":"10.1155\/2010\/957507","volume":"2010","author":"O Picone","year":"2010","unstructured":"Picone O, Donnadieu AC, Brivet FG, Boyer-Neumann C, Fremeaux-Bacchi V, Frydman R. Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene. Obstet Gynecol Int. 2010;2010:957507.","journal-title":"Obstet Gynecol Int"},{"issue":"7","key":"1570_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1398-9995.2011.02562.x","volume":"66","author":"ML Baeza","year":"2011","unstructured":"Baeza ML, Rodriguez-Marco A, Prieto A, Rodriguez-Sainz C, Zubeldia JM, Rubio M. Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III. Allergy. 2011;66(7):981\u20132.","journal-title":"Allergy"},{"issue":"3","key":"1570_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","volume":"109","author":"C Marcos","year":"2012","unstructured":"Marcos C, Lopez Lera A, Varela S, Linares T, Alvarez-Eire MG, Lopez-Trascasa M. Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families. Ann Allergy Asthma Immunol. 2012;109(3):195-200e192.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1570_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jaci.2013.04.032","volume":"132","author":"C Gomez-Traseira","year":"2013","unstructured":"Gomez-Traseira C, Lopez Lera A, Drouet C, Lopez-Trascasa M, Perez-Fernandez E, Favier B, et al. Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease. J Allergy Clin Immunol. 2013;132(4):986\u20139.","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"1570_CR28","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/all.12515","volume":"69","author":"D Charignon","year":"2014","unstructured":"Charignon D, Ghannam A, Defendi F, Ponard D, Monnier N, Lopez-Trascasa M, Launay D, et al. Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype. Allergy. 2014;69(12):1659\u201365.","journal-title":"Allergy"},{"issue":"2","key":"1570_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000376547","volume":"166","author":"AS Moreno","year":"2015","unstructured":"Moreno AS, Valle SO, Levy S, Franca AT, Serpa FS, Arcuri HA, et al. Coagulation factor XII gene mutation in brazilian families with hereditary angioedema with normal C1 inhibitor. Int Arch Allergy Immunol. 2015;166(2):114\u201320.","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"1570_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/joim.12304","volume":"277","author":"M Mansi","year":"2015","unstructured":"Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R, et al. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med. 2015;277(5):585\u201393.","journal-title":"J Intern Med"},{"issue":"4","key":"1570_CR31","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bjd.13791","volume":"173","author":"C Stieber","year":"2015","unstructured":"Stieber C, Grumach AS, Cordeiro E, Constantino-Silva RN, Barth S, Hoffmann P, et al. First report of a FXII gene mutation in a Brazilian family with hereditary angio-oedema with normal C1 inhibitor. Br J Dermatol. 2015;173(4):1102\u20134.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1570_CR32","first-page":"57","volume":"26","author":"AS Moreno","year":"2016","unstructured":"Moreno AS, Maia LS, Palhas PB, Dias MM, Muglia VF, Castelli EC, et al. Genetic analysis as a practical tool for diagnosis of hereditary angioedema with normal C1 inhibitor: a case report. J Investig Allergol Clin Immunol. 2016;26(1):57\u20139.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"1570_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cei.12820","volume":"185","author":"A Deroux","year":"2016","unstructured":"Deroux A, Boccon-Gibod I, Fain O, Pralong P, Ollivier Y, Pagnier A, et al. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Clin Exp Immunol. 2016;185(3):332\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1570_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/all.12769","volume":"71","author":"AS Grumach","year":"2016","unstructured":"Grumach AS, Stieber C, Veronez CL, Cagini N, Constantino-Silva RN, Cordeiro E, et al. Homozygosity for a factor XII mutation in one female and one male patient with hereditary angio-oedema. Allergy. 2016;71(1):119\u201323.","journal-title":"Allergy"},{"issue":"5","key":"1570_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.anai.2016.09.001","volume":"117","author":"M Pi\u00f1ero-Saavedra","year":"2016","unstructured":"Pi\u00f1ero-Saavedra M, Gonzalez-Quevedo T, Saenz de San Pedro B, Alcaraz C, Bobadilla-Gonzalez P, Fernandez-Vieira L, et al. Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families. Ann Allergy Asthma Immunol. 2016;117(5):520\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"1570_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/all.13076","volume":"72","author":"K Bork","year":"2017","unstructured":"Bork K, Wulff K, Witzke G, Hardt J. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy. 2017;72(2):320\u20134.","journal-title":"Allergy"},{"issue":"6","key":"1570_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.anai.2017.04.014","volume":"118","author":"CL Veronez","year":"2017","unstructured":"Veronez CL, Serpa FS, Pesquero JB. A rare mutation in the F12 gene in a patient with ACE inhibitor-induced angioedema. Ann Allergy Asthma Immunol. 2017;118(6):743\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1570_CR38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaip.2017.09.025","volume":"6","author":"CL Veronez","year":"2018","unstructured":"Veronez CL, Moreno AS, Constantino-Silva RN, Maia LSM, Ferriani MPL, Castro FFM, et al. Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families. J Allergy Clin Immunol Pract. 2018;6(4):1209\u201316.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"1570_CR39","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/all.14160","volume":"75","author":"M Bova","year":"2019","unstructured":"Bova M, Suffritti C, Bafunno V, Loffredo S, Cordisco G, Del Giacco S, et al. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor. Allergy. 2019;75(6):1394\u2013403.","journal-title":"Allergy"},{"issue":"12","key":"1570_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.amjmed.2013.05.017","volume":"126","author":"K Bork","year":"2013","unstructured":"Bork K, Wulff K, Witzke G, Stanger C, Lohse P, Hardt J. Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations. Am J Med. 2013;126(12):1142\u20139.","journal-title":"Am J Med"},{"issue":"5","key":"1570_CR41","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1111\/hae.12519","volume":"20","author":"K Bork","year":"2014","unstructured":"Bork K, Wulff K, Hardt J, Witzke G, Lohse P. Characterization of a partial exon 9\/intron 9 deletion in the coagulation factor XII gene (F12) detected in 2 Turkish families with hereditary angioedema and normal C1 inhibitor. Haemophilia. 2014;20(5):e372-375.","journal-title":"Haemophilia"},{"issue":"2","key":"1570_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clim.2015.02.013","volume":"157","author":"D Firinu","year":"2015","unstructured":"Firinu D, Bafunno V, Vecchione G, Barca MP, Manconi PE, Santacroce R, et al. Characterization of patients with angioedema without wheals: the importance of F12 gene screening. Clin Immunol. 2015;157(2):239\u201348.","journal-title":"Clin Immunol"},{"issue":"3","key":"1570_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.transci.2003.08.002","volume":"29","author":"KE Binkley","year":"2003","unstructured":"Binkley KE, Davis AE 3rd. Estrogen-dependent inherited angioedema. Transfus Apher Sci. 2003;29(3):215\u20139.","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"1570_CR44","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","volume":"120","author":"K Bork","year":"2007","unstructured":"Bork K, Gul D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med. 2007;120(11):987\u201392.","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"1570_CR45","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","volume":"33","author":"BL Zuraw","year":"2012","unstructured":"Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, et al. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33(Suppl 1):S145-156.","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"1570_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1684\/ejd.2016.2948","volume":"27","author":"L Bouillet","year":"2017","unstructured":"Bouillet L, Boccon-Gibod I, Gompel A, Floccard B, Martin L, Blanchard-Delaunay C, et al. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert(I)) in a French cohort. Eur J Dermatol. 2017;27(2):155\u20139.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"1570_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S1081-1206(10)60369-9","volume":"103","author":"L Bouillet","year":"2009","unstructured":"Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol. 2009;103(5):448.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"1570_CR48","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jaip.2017.12.022","volume":"6","author":"JFB Garcia","year":"2018","unstructured":"Garcia JFB, Takejima P, Veronez CL, Aun MV, Motta AA, Kalil J, et al. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH. J Allergy Clin Immunol Pract. 2018;6(4):1406\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1570_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13223-019-0346-1","volume":"15","author":"DL Bodian","year":"2019","unstructured":"Bodian DL, Vilboux T, Hauser NS. Genotype-first analysis of a generally healthy population cohort supports genetic testing for diagnosis of hereditary angioedema of unknown cause. Allergy Asthma Clin Immunol. 2019;15:32.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1570_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13601-019-0247-x","volume":"9","author":"A Recke","year":"2019","unstructured":"Recke A, Massalme EG, Jappe U, Steinmuller-Magin L, Schmidt J, Hellenbroich Y, et al. Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema. Clin Transl Allergy. 2019;9:9.","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"1570_CR51","first-page":"215","volume":"18","author":"K Bork","year":"2020","unstructured":"Bork K, Zibat A, Ferrari DM, Wollnik B, Schon MP, Wulff K, et al. Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes. J Dtsch Dermatol Ges. 2020;18(3):215\u201323.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"1570_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13023-020-1334-8","volume":"15","author":"K Bork","year":"2020","unstructured":"Bork K, Wulff K, Witzke G, Machnig T, Hardt J. Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene. Orphanet J Rare Dis. 2020;15(1):52.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1570_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2017.12.060","volume":"498","author":"G Dewald","year":"2018","unstructured":"Dewald G. A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2018;498(1):193\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1570_CR54","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/all.13324","volume":"73","author":"AE Germenis","year":"2018","unstructured":"Germenis AE, Loules G, Zamanakou M, Psarros F, Gonzalez-Quevedo T, Speletas M, et al. On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema. Allergy. 2018;73(8):1751\u20133.","journal-title":"Allergy"},{"issue":"11","key":"1570_CR55","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1111\/all.13543","volume":"73","author":"A Belbezier","year":"2018","unstructured":"Belbezier A, Hardy G, Marlu R, Defendi F, Dumestre-Perard D, Boccon-Gibod I, et al. Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families. Allergy. 2018;73(11):2237\u20139.","journal-title":"Allergy"},{"issue":"11","key":"1570_CR56","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/all.13550","volume":"73","author":"H Yakushiji","year":"2018","unstructured":"Yakushiji H, Hashimura C, Fukuoka K, Kaji A, Miyahara H, Kaname S, et al. A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan. Allergy. 2018;73(11):2244\u20137.","journal-title":"Allergy"},{"issue":"5","key":"1570_CR57","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.jaci.2016.02.021","volume":"138","author":"S de Maat","year":"2016","unstructured":"de Maat S, Bjorkqvist J, Suffritti C, Wiesenekker CP, Nagtegaal W, Koekman A, et al. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J Allergy Clin Immunol. 2016;138(5):1414\u201323.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1570_CR58","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1182\/blood-2018-06-860270","volume":"133","author":"I Ivanov","year":"2019","unstructured":"Ivanov I, Matafonov A, Sun MF, Mohammed BM, Cheng Q, Dickeson SK, et al. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain. Blood. 2019;133(10):1152\u201363.","journal-title":"Blood"},{"key":"1570_CR59","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3389\/fimmu.2019.02046","volume":"10","author":"C Maas","year":"2019","unstructured":"Maas C. Plasminflammation\u2014an emerging pathway to bradykinin production. Front Immunol. 2019;10:2046.","journal-title":"Front Immunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01570-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T11:42:07Z","timestamp":1634298127000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01570-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Konrad Bork reports speaker fees from CSL Behring and Shire\/Takeda, outside the submitted work; Thomas Machnig is a former employee of CSL Behring; Subhransu Prusty is an employee of CSL Behring; Karin Wulff, Guenther Witzke and Jochen Hardt declare that they do not have any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}